Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)

NCT00032487 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1791

Enrollment

FED

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Insulin
DRUG: Glimepiride
DRUG: Rosiglitazone
DRUG: Metformin

Sponsor

VA Office of Research and Development

Collaborators

[object Object]
[object Object]